Feed GNFT
GN

Genfit S.A. GNFT NASDAQ · Healthcare · France

$7.82 -6.18% -$0.52

Market cap
328.5M €
Enterprise value
359.9M €
P/E
-
Forward P/E
-
PEG
-
P/S
2.5x
P/FCF
-
EV/EBITDA
14.5x
ROIC
12.4%
Gross margin
100.4%
Net margin
5.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
1.3x
Beta
0.87
Free float
87.9%

Sector

Healthcare

Industry

Biotechnology

CEO

M. Pascal Prigent

Employees

180

Headquarters

Loos

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

  • What to watch: Revenue fell by 13% a year over the last 3 years.
  • What to watch: It missed profit estimates 4 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: It earns 12 EUR a year on every 100 EUR of invested capital.
  • What to watch: It reports a profit, yet spends more cash than it brings in.

Financial health

Can it carry its debt?

  • What speaks for it: It could repay all its net debt from 1.3 years of operating profit.
  • What to watch: It passes only 2 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy